Details

Analysis of the SARS-CoV-2 main protease and presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants, CCDR 50(10) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 19, 2025 · edition #1
Timestamp: 2025-04-19T05:03:29.289Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/analysis-sars-cov-2-main-protease-presence-nirmatrelvir-resistant-omicron-mutants.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250419050329/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/analysis-sars-cov-2-main-protease-presence-nirmatrelvir-resistant-omicron-mutants.html?wbdisable=true#ha_snapshot=161813
ID: 161813
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots